Safety, tolerability, pharmacokinetics, and pharmacodynamics of TG103 injection in participants who are overweight or obese: a randomized, double-blind, placebo-controlled, multiple-dose phase 1b study
Diaozhu Lin(Sun Yat-sen University), Li Yan(Peking University), Lei Huang(Nanjing Drum Tower Hospital), Yanqiong Liu(Wuhan University), Huanhuan Gao(Montreal Heart Institute), Kexu Yang(Capital Medical University), Huisheng Xiao(Sun Yat-sen University), Ying Xie(CSPC Pharmaceutical Group), Shan Jing(Capital Medical University), Jing Yuan(Capital Institute of Pediatrics), Juan Li(Third People's Hospital of Chengdu), Ziyan Li(Delft University of Technology), Mingtong Xu(Sun Yat-sen University), Yuanxun Yang(Nanjing Drum Tower Hospital), Suiwen Ye(Sun Yat-sen University), Jinlan Yang(CSPC Pharmaceutical Group), Lin Yang(Capital Medical University)
Cited by 5
Related Papers
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
|Cell Metabolism|2020|1.7k
Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay
|Clinical Microbiology and Infection|2020|549
Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae
|Cell Metabolism|2019|521
Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis
|Journal of Antimicrobial Chemotherapy|2019|239
Associations of lipid parameters with insulin resistance and diabetes: A population-based study
|Clinical Nutrition|2017|183